Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.

Abstract

OBJECTIVE To update the results with 10-year data of a phase II prospective trial of neoadjuvant hormonal therapy with goserelin acetate and flutamide followed by radical prostatectomy for locally advanced prostate cancer (SWOG 9109). The optimal management for clinical stage T3 and T4 N0,M0 prostate cancer is uncertain. MATERIALS AND METHODS Sixty-two… (More)
DOI: 10.1016/j.urology.2011.11.019

Topics

4 Figures and Tables

Cite this paper

@article{Berglund2012TenyearFO, title={Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.}, author={Ryan K Berglund and Catherine Marie Tangen and Isaac J. Powell and Bruce A. Lowe and Gabriel P. Haas and Peter R. Carroll and Edith D Canby-Hagino and Ralph W. deVere White and George P. Hemstreet and E. David Crawford and Ian M. Thompson and Eric A. Klein}, journal={Urology}, year={2012}, volume={79 3}, pages={633-7} }